Environmental Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Korea.
Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Korea.
Exp Mol Med. 2021 Jun;53(6):1007-1017. doi: 10.1038/s12276-021-00634-7. Epub 2021 Jun 1.
Necroptosis is a form of programmed necrosis that is mediated by various cytokines and pattern recognition receptors (PRRs). Cells dying by necroptosis show necrotic phenotypes, including swelling and membrane rupture, and release damage-associated molecular patterns (DAMPs), inflammatory cytokines, and chemokines, thereby mediating extreme inflammatory responses. Studies on gene knockout or necroptosis-specific inhibitor treatment in animal models have provided extensive evidence regarding the important roles of necroptosis in inflammatory diseases. The necroptosis signaling pathway is primarily modulated by activation of receptor-interacting protein kinase 3 (RIPK3), which phosphorylates mixed-lineage kinase domain-like protein (MLKL), mediating MLKL oligomerization. In the necroptosis process, these proteins are fine-tuned by posttranslational regulation via phosphorylation, ubiquitination, glycosylation, and protein-protein interactions. Herein, we review recent findings on the molecular regulatory mechanisms of necroptosis.
细胞坏死是一种受多种细胞因子和模式识别受体(PRRs)调控的程序性细胞坏死形式。坏死性细胞死亡的细胞表现出坏死表型,包括肿胀和膜破裂,并释放损伤相关分子模式(DAMPs)、炎性细胞因子和趋化因子,从而介导极端的炎症反应。在动物模型中对基因敲除或坏死性细胞死亡特异性抑制剂的研究提供了广泛的证据,证明了坏死性细胞死亡在炎症性疾病中的重要作用。坏死性细胞死亡信号通路主要通过受体相互作用蛋白激酶 3(RIPK3)的激活来调节,RIPK3 磷酸化混合谱系激酶结构域样蛋白(MLKL),介导 MLKL 寡聚化。在坏死性细胞死亡过程中,这些蛋白通过磷酸化、泛素化、糖基化和蛋白-蛋白相互作用等翻译后调控进行精细调节。在此,我们综述了关于坏死性细胞死亡分子调控机制的最新发现。